[1]
Z. Kamil, “Additive Effect of Supratarsal Olopatadine HCL 0.1% Injection In Patients of Vernal Keratoconjunctivitis On Topical Olopatadine”, jsp, vol. 25, no. 4, pp. 139-42, Feb. 2021.